Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 900 participants.
Also called NCT06591377
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 900 participants
- Sponsor
- Registry
-
NCT06591377
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Recruiting
Technical summary
Registry record NCT06591377. Randomized; double masking; primary purpose treatment. Start 2024-08-10 (actual); primary completion 2025-09-19 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Ticagrelor 90 MG
- Intervention (Drug)
- Cilostazol 100 MG
- Intervention (Drug)
- Aspirin 75mg
- Intervention (Drug)
- Aspirin 75mg
- Lead sponsor
- Kafrelsheikh University
- Collaborator
- El-Sahel Teaching Hospital
Record details
- Record id
cardio:ct-nct06591377- Content hash
6abc055b4b510980d5818911cb7f642812a5a214641e0afbe3ffcd2b558dfa3a